Cronos Group Inc. reported $179M of revenue over the trailing twelve months, +37% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $179M (to Q2 2026). Net income: $70M, trailing twelve months to Q2 2026. Free cash flow: $50M, trailing twelve months to Q2 2026. Operating margin: −2.1%, trailing twelve months to Q2 2026.

CRONCronos Group Inc.

Healthcare

$3.23+23% 1Y

$3.23

$2.3052 weeks$3.55

CRON as reported

Cronos Group Inc. reported $179M of revenue over the trailing twelve months, +37% on the year before. 10 reported series are charted on this page, each one as filed.

$179M

Revenue, trailing twelve months · to Q2 2026 · +37% against the twelve months before

Net income: $70M
Net income · +278% year on year · trailing twelve months to Q2 2026
Free cash flow: $50M
Free cash flow · −652% year on year · trailing twelve months to Q2 2026
Operating margin: −2.1%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for CRON, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$179M	+37%	Q2 2026
Net income	$70M	+278%	Q2 2026
EPS	$0.20	+233%	Q2 2026
Gross margin	46%	n/a	Q2 2026
Operating margin	−2.1%	n/a	Q2 2026
Net margin	40%	n/a	Q2 2026
ROE	2.2%	n/a	Q2 2026
ROA	2.0%	n/a	Q2 2026
Free cash flow	$50M	−652%	Q2 2026
P/E	16.1	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.